Provided is a crystalline form of nateglinide, labeled Forms and , processes for its preparation. Also provided are its pharmaceutical formulations and methods of administration.
申请公布号
WO2004067496(A9)
申请公布日期
2004.12.09
申请号
WO2004US00839
申请日期
2004.01.13
申请人
TEVA PHARMACEUTICAL INDUSTRIES LTD.;TEVA PHARMACEUTICALS USA, INC.;FRENKEL, GUSTAVO;GOME, BOAZ;WIZEL, SHLOMIT
